Financials

News Ideas Technicals Forecast

MAAT fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to MAAT PHARMA operating, investing, and financing activities

MAAT free cash flow for H2 23 is -5.85 M EUR. For 2023, MAAT free cash flow was -19.3 M EUR and operating cash flow was -18.21 M EUR.

‪0.00‬

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: EUR

TTM

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—